XBI icon

SPDR S&P Biotech ETF

180 hedge funds and large institutions have $2.76B invested in SPDR S&P Biotech ETF in 2015 Q1 according to their latest regulatory filings, with 50 funds opening new positions, 48 increasing their positions, 47 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

2% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 47

65% less call options, than puts

Call options by funds: $245M | Put options by funds: $701M

74.31% less ownership

Funds ownership: 463.38%389.07% (-74%)

Holders
180
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$245M
Puts
$701M
Net Calls
Net Calls Change

Top Buyers

1 +$115M
2 +$114M
3 +$113M
4
UBS Group
UBS Group
Switzerland
+$73.7M
5
Goldman Sachs
Goldman Sachs
New York
+$72.3M

Top Sellers

1 -$205M
2 -$178M
3 -$17.8M
4
SCM
Sandler Capital Management
New York
-$8.13M
5
VF
Virtu Financial
New York
-$5.93M
Name Holding Trade Value Shares
Change
Change in
Stake
151
$94K
152
$84K
153
$78K
154
$71K
155
$64K
156
$56K
157
$54K
158
$53K
159
$45K
160
$45K
161
$34K
162
$34K
163
$34K
164
$34K
165
$30K
166
$28K
167
$27K
168
$27K
169
$24K
170
$23K
171
$23K
172
$11K
173
$11K
174
$6K
175
$6K